When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans

References

1. Sharma NC, Efstratiou A, Mokrousov I, Mutreja A, Das B et al. Diphtheria. Nat Rev Dis Primers 2019; 5:81 [View Article] [PubMed]
   [Google Scholar]
2. Badell E, Alharazi A, Criscuolo A, Almoayed KAA, Lefrancq N et al. Ongoing diphtheria outbreak in Yemen: a cross-sectional and genomic epidemiology study. Lancet Microbe 2021; 2:e386–e396 [View Article] [PubMed]
   [Google Scholar]
3. Polonsky JA, Ivey M, Mazhar MKA, Rahman Z, le Polain de Waroux O et al. Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox’s Bazar, Bangladesh, 2017 to 2019: a retrospective study. PLoS Med 2021; 18:e1003587 [View Article] [PubMed]
   [Google Scholar]
4. Adegboye OA, Alele FO, Pak A, Castellanos ME, Abdullahi MAS et al. A resurgence and re-emergence of diphtheria in Nigeria, 2023. Ther Adv Infect Dis 2023; 10:20499361231161936 [View Article] [PubMed]
   [Google Scholar]
5. European centre for disease prevention and control (ECDC) Diphtheria - Annual Epidemiological Report; 2022 https://www.ecdc.europa.eu/sites/default/files/documents/DIPH_AER_2022_Report.pdf
6. Wagner KS, White JM, Neal S, Crowcroft NS, Kuprevičiene N et al. Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study. Clin Microbiol Infect 2011; 17:519–525 [View Article] [PubMed]
   [Google Scholar]
7. Gower CM, Scobie A, Fry NK, Litt DJ, Cameron JC et al. The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017. Euro Surveill 2020; 25:1900462 [View Article] [PubMed]
   [Google Scholar]
8. Martini H, Soetens O, Litt D, Fry NK, Detemmerman L et al. Diphtheria in Belgium: 2010-2017. J Med Microbiol 2019; 68:1517–1525 [View Article] [PubMed]
   [Google Scholar]
9. Bonmarin I, Guiso N, Le Flèche-Matéos A, Patey O, Patrick ADG et al. Diphtheria: a zoonotic disease in France?. Vaccine 2009; 27:4196–4200 [View Article] [PubMed]
   [Google Scholar]
10. Yamamoto A, Hifumi T, Ato M, Iwaki M, Senoh M et al. Clinical characteristics of Corynebacterium ulcerans infection, Japan. Emerg Infect Dis 2023; 29:1505–1515 [View Article]
    [Google Scholar]
11. Otshudiema JO, Acosta AM, Cassiday PK, Hadler SC, Hariri S et al. Respiratory illness caused by Corynebacterium diphtheriae and C. ulcerans, and use of diphtheria antitoxin in the United States, 1996-2018. Clin Infect Dis 2021; 73:e2799–e2806 [View Article] [PubMed]
    [Google Scholar]
12. Hillan A, Gibbs T, Weaire-Buchanan G, Brown T, Pang S et al. Zoonotic transmission of diphtheria toxin-producing Corynebacterium ulcerans. Zoo Public Health 2024; 71:157–169 [View Article] [PubMed]
    [Google Scholar]
13. Konrad R, Hörmansdorfer S, Sing A. Possible human-to-human transmission of toxigenic Corynebacterium ulcerans. Clin Microbiol Infect 2015; 21:768–771 [View Article] [PubMed]
    [Google Scholar]
14. Hacker E, Antunes CA, Mattos-Guaraldi AL, Burkovski A, Tauch A. Corynebacterium ulcerans, an emerging human pathogen. Future Microbiol 2016; 11:1191–1208 [View Article] [PubMed]
    [Google Scholar]
15. Berger A, Badell E, Åhman J, Matuschek E, Zidane N et al. Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints. J Antimicrob Chemother 2024; 79:968–976 [View Article] [PubMed]
    [Google Scholar]
16. WHO/UNICEF Estimates of National Immunization Coverage (WUENIC). https://immunizationdata.who.int/global/wiise-detail-page/diphtheria-tetanus-toxoid-and-pertussis-(dtp)-vaccination-coverage?CODE=EUR&ANTIGEN=DTPCV3&YEAR=
17. Berbers G, van Gageldonk P, Kassteele J van de, Wiedermann U, Desombere I et al. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries. Nat Commun 2021; 12:2871 [View Article] [PubMed]
    [Google Scholar]
18. Wagner A, Jasinska J, Schmid D, Kundi M, Wiedermann U. Lack of seroprotection against diphtheria in the Austrian population. Euro Surveill 2022; 28:2300206 [View Article] [PubMed]
    [Google Scholar]
19. von Hunolstein C, Rota MC, Alfarone G, Ricci ML, Salmaso S. Diphtheria antibody levels in the Italian population. Eur J Clin Microbiol Infect Dis 2000; 19:433–437 [View Article]
    [Google Scholar]
20. Gao H, Lau EHY, Cowling BJ. Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis. J Infect Dis 2022; 225:557–566 [View Article] [PubMed]
    [Google Scholar]
21. Center for Disease Control (CDC) Diphtheria, tetanus, and pertussis vaccine recommendations. https://www.cdc.gov/vaccines/vpd/dtap-tdap-td/hcp/recommendations.html#:~:text=CDC%20recommends%20diphtheria%2C%20tetanus%2C%20and,adults%20receive%20Tdap%20and%20Td
22. Möller J, Kraner M, Sonnewald U, Sangal V, Tittlbach H et al. Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae. Vaccine 2019; 37:3061–3070 [View Article] [PubMed]
    [Google Scholar]
23. Meinel DM, Margos G, Konrad R, Krebs S, Blum H et al. Next generation sequencing analysis of nine Corynebacterium ulcerans isolates reveals zoonotic transmission and a novel putative diphtheria toxin-encoding pathogenicity island. Genome Med 2014; 6: [View Article]
    [Google Scholar]
24. Otsuji K, Fukuda K, Ogawa M, Saito M. Mutation and diversity of diphtheria toxin in Corynebacterium ulcerans. Emerg Infect Dis 2019; 25:2122–2123 [View Article] [PubMed]
    [Google Scholar]
25. Mancini F, Monaco M, Pataracchia M, von Hunolstein C, Pantosti A et al. Identification and molecular discrimination of toxigenic and nontoxigenic diphtheria Corynebacterium strains by combined real-time polymerase chain reaction assays. Diagn Microbiol Infect Dis 2012; 73:111–120 [View Article] [PubMed]
    [Google Scholar]
26. Konrad R, Berger A, Huber I, Boschert V, Hörmansdorfer S et al. Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill 2010; 15:19699 [View Article] [PubMed]
    [Google Scholar]